Kliniska prövningar Nct sida
Clinical Trial Results:
A multicentre open-label, dose-escalation, trial of zanolimumab in combination with CHOP chemotherapy in subjects with CD4 positive non-cutaneous peripheral T-Cell Lymphoma with nodal involvement
PREMATURELY ENDED
| Summary | |
EudraCT number | 2006-004516-51 |
Trial protocol | NL DE IT |
Global completion date | |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | |
| Results information | |
Results version number | v1(current) |
This version publication date | 06 Apr 2022 |
First version publication date | 06 Apr 2022 |
Other versions | |
Summary report(s) | Results Summary - Clinical Study Report Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.